Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion

Overview upon miR-21 in lung cancer: focus on NSCLC

(2018) Cecilia Bica-Pop et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Pleural Disease

(2018) David Feller-Kopman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

(2018) Wan-Wei Wang et al.   OncoTargets and Therapy

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway

(2018) Wan Li et al.   Clinical Epigenetics

MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma

(2017) Lipin Liu et al.   Molecular Cancer

MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene

(2017) Yongwen Li et al.   MOLECULAR CARCINOGENESIS

Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis

(2017) Yuan Yang et al.   RESPIRATION

A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer

(2017) Ji-Guang Han et al.   Annals of Surgical Treatment and Research

Diagnostic accuracy of tumor markers for malignant pleural effusion: a derivation and validation study

(2017) Kan Zhai et al.   Journal of Thoracic Disease

Management of malignant pleural effusion: challenges and solutions

(2017) Erika Penz et al.   Cancer Management and Research

MiR 21-5p as a predictor of recurrence in young gastric cancer patients

(2016) Soo-Kyung Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia

(2016) Jin Lin et al.   TUMOR BIOLOGY

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer

(2016) WangYu Zhu et al.   PLoS One

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma

(2015) KEIKO MIZUNO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1

(2015) Seung-Myoung Son et al.   PATHOLOGY

Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin

(2015) Zhenhua Yang et al.   PLoS One

MicroRNAome genome: A treasure for cancer diagnosis and therapy

(2014) Ioana Berindan-Neagoe et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer

(2014) Wangyu Zhu et al.   PLoS One

Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia

(2013) Amal A. Abd-El-Fattah et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues

(2013) Qing-He Zhang et al.   GENE

Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion

(2013) Hye-Suk Han et al.   INTERNATIONAL JOURNAL OF CANCER

High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer

(2013) Naohide Oue et al.   INTERNATIONAL JOURNAL OF CANCER

microRNA detection in feces, sputum, pleural effusion and urine: Novel tools for cancer screening (Review)

(2013) YU-FENG XIAO et al.   ONCOLOGY REPORTS

Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis

(2013) Xing Zhang et al.   PLoS One

Higher expression of circulating miR-182 as a novel biomarker for breast cancer

(2013) PING-YU WANG et al.   Oncology Letters

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early Recurrence

(2012) Tai-Yue Kuo et al.   PLoS One

Diagnosis and Treatment of Malignant Pleural Effusion

(2010) Giuseppe Lombardi et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

The MicroRNA Spectrum in 12 Body Fluids

(2010) J. A. Weber et al.   CLINICAL CHEMISTRY

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

Medical thoracoscopy

(2009) Roberto F Casal et al.   CURRENT OPINION IN PULMONARY MEDICINE

Management of Malignant Pleural Effusions

(2008) Marcelo Spector et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis

(2007) Q-L Liang et al.   THORAX